Skip to content

13F-HR filed by RBF Capital, LLC

RBF Capital, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 529 holding rows worth $1,186,810,000.

Accession
0001062993-22-021924
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 529 entries on the cover page, a total value of $1,186,810,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,186,810,000 with VALUE read as thousands by filing date, 13F file number 028-06357. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NAUTILUS INC63910B102COMMON STOCK52,800$86,000thousands by filing date
XBIOTECH INC98400H102COM23,172$84,000thousands by filing date
CARROLS RESTAURANT GROUP INC14574X104COM50,000$82,000thousands by filing date
MIND TECHNOLOGY INC COM NEW602566101Stock127,383$82,000thousands by filing date
COGNYTE SOFTWARE LTDM25133105ORD SHS20,000$81,000thousands by filing date
HORIZON GLOBAL CORP44052W104COM60,000$74,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock156,900$73,000thousands by filing date
MARCHEX INC56624R108CMN41,600$70,000thousands by filing date
SIGMATRON INTL INC82661L101COM14,141$67,000thousands by filing date
SALEM MEDIA GROUP INC CLASS A794093104COM34,200$60,000thousands by filing date
AMPCO-PITTSBURG CORP032037111*W EXP 08/01/202211,652$57,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM102,095$51,000thousands by filing date
DIVERSIFIED HEALTHCARE TR25525P107COM SH BEN INT50,000$50,000thousands by filing date
RENEO PHARMACEUTICALS INC75974E103COM14,536$49,000thousands by filing date
CUE BIOPHARMA INC22978P106COM20,000$45,000thousands by filing date
INVACARE CORP461203101COMMON STOCK54,553$43,000thousands by filing date
Cango Inc/KY137586103ADS18,255$42,000thousands by filing date
ALLOT LTDM0854Q105SHS10,360$41,000thousands by filing date
REGIS CORP758932107COM40,401$41,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK13,000$35,000thousands by filing date
QUANTUM CORP747906501COM29,900$32,000thousands by filing date
Xilio Therapeutics Inc.98422T100COM10,072$29,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK13,800$27,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM30,000$26,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM14,741$24,000thousands by filing date
ENGLOBAL CORP293306106COM18,915$24,000thousands by filing date
Tuya Inc90114C107COM24,800$23,000thousands by filing date
WILLIAMS INDUSTRIAL SERVICES96951A104COMMON STOCK14,000$21,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW11,654$16,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062993-22-021924this filing2022-11-14acceptance time not in the bulk data set